The directorate general of Health Services (DGHS), under the Central Drugs Standard Control Organisation (CDSCO), recently suspended ENTOD Pharmaceuticals’ licence to manufacture and market ...

Due to safety concerns and unauthorised claims, the Central Drugs Standard Control Organisation (CDSCO) of India has suspended the manufacturing and marketing license of Entod Pharmaceuticals’ PresVu ...

ENTOD Pharmaceuticals has recently launched PresVu eye drops, which have been approved by the Drug Controller General of India (DCGI). Marketed as a potential breakthrough for presbyopia — a common ...

PresVu is the result of years of dedicated research and development, the company claims. (Image Credits: Pixabay) Days, after ENTOD Pharmaceuticals announced that it has received final approval from ...

New Delhi [India], September 5 (ANI): The claims made by ENTOD Pharmaceuticals about its product PresVU eye drops being approved by DCGI and offering spectacular treatment for Presbyopia are unethical ...

Entod Pharmaceuticals' Chief Executive Officer (CEO) Nikkhil K Masurkar said that the company will challenge the Drugs Controller General of India's (DCGI) order suspending manufacturing and marketing ...

PresVu eye drops are not intended to replace reading glasses or non-invasive options for presbyopia, ENOTD Pharma has informed Drug Controller General of India ENTOD Pharmaceuticals, whose eye drop ...

The Drugs Controller General of India (DCGI) has suspended the approval granted to Mumbai-based Entod Pharmaceuticals for manufacturing and sale of its eye drops— PresVu— for aggressively overselling ...

Any future launch of PresVu eye drops would include nationwide academic sessions with eye doctors, the company claimed. (Image Credits: Pixabay) Mumbai-based ENTOD Pharmaceuticals on Thursday ...

Mumbai-based Entod Pharmaceuticals met with the Drug Controller General of India (DCGI) earlier this week to address concerns surrounding pilocarpine hydrochloride ophthalmic solution USP 1.25% w/v ...

Drug Controller General of India (DCGI) on Tuesday gave Entod Pharmaceuticals an approval to market its eye drops for the treatment of presbyopia, a possible major breakthrough in treating poor ...